How to Use Eptifibatide
Complete guide to Eptifibatide dosing, administration, timing, and protocol recommendations.
Quick Overview
Eptifibatide is an FDA-approved intravenous antiplatelet drug, sold as Integrilin, and it has an oddly cool origin: it is a synthetic cyclic heptapeptide modeled on barbourin, a protein from the venom of the southeastern pygmy rattlesnake. It is used in hospitals during acute coronary syndromes and percutaneous coronary intervention (PCI, the stent procedure) to stop platelets from clumping and forming dangerous clots. This is a real, approved cardiac drug, not a wellness or research peptide.
Dosing Guidelines
Common Dose
Limited community data available
Frequency
See research protocols
Dose Range
See research dosing
Note: Limited anecdotal data. Refer to research dosing section.
Administration Method
IV bolus and infusion
Best Time to Take
Morning or as directed
Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.
Protocol Duration
Up to 72 hours
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Bleeding (28% - most common)
- •Major bleeding (3-10%)
- •Hypotension
- •Thrombocytopenia
- •Allergic reactions
Frequently Asked Questions
What is the recommended dose for Eptifibatide?
Limited community data available
How do you administer Eptifibatide?
IV bolus and infusion
When is the best time to take Eptifibatide?
Morning or as directed
How long should you use Eptifibatide?
Up to 72 hours
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.